Emerald Medical Applications Corp. - Statements of Operations	3 Months Ended
	Mar. 31, 2016 USD ($) $ / shares shares	Mar. 31, 2015 USD ($) $ / shares shares
Statements of Operations
Revenue	$ 0	$ 0
Expenses:
Research and development	(103,348)	0
General and administrative expenses	(1,799,520)	(178,725)
Total operating expenses	$ (1,902,868)	$ (178,725)
(Loss) from operations	(1,902,868)	(178,725)
Other income (expense):
Interest expense	$ (7,759)	$ (7,483)
Change in fair value of derivative	0	367
Depreciation expense	$ (2,509)	$ (399)
Amortizatio expense	$ (1,438)	$ 0
Gain/loss from foreign currency	14,344	5,918
Financial income (expense)	2,638	(1,597)
Total income (expense)	(1,900,230)	(180,322)
Provision for income taxes	0	0
Net (loss)	$ (1,900,230)	$ (180,322)
Basic and diluted net loss per share | $ / shares	$ (0.11)	$ (0.85)
Weighted average shares outstanding
Basic and diluted | shares	17,351,957	213,001